- Remark Holdings is set to open moderately lower, alongside other stocks.
- A small stake in a company backed by Dr. Mehmet Oz may help the shares rise, especially if it reaches an IPO.
- Demand for coronavirus-related products could also boost NASDAQ:MARK.
NASDAQ:MARK is trading around $2.50 in pre-market trading, marginally lower. That comes after Remark Holdings Inc advanced to $2.62 on Monday, alongside the broader stock market.
It has set a higher lows but also lower highs in recent days – a narrowing range in comparison to May's rally from around $0.50 to a peak close of $3.40. Where next for the stock?
Mark stock news
The S&P 500 is set for a correction after erasing all the losses for the year. Investors are becoming more cautious ahead of Wednesday's Federal Reserve decision. The central bank may opt to take a break after stimulating the economy in response to the coronavirus crisis, and the robust rally needs occasional breathers.
Another fear is the second wave of COVID-19 cases. While Europe, most of Asia, and the original US hotspots have the disease under control, cases are rising in other American states and in Latin America.
That may be favorable for Remark Holdings, which makes thermal scanners, such as those used to detect people who have a high fever. The kit, already in use in the company's home state of Nevada, joins other AI products that are in demand, especially in China.
The Las Vegas-based company also received a "strong-buy" recommendation from Zacks, potentially sending additional investors its way.
Another reason to rise could be Remark's stake at Sharecare. The startup firm was co-founded by celebrity doctor Mehmet Oz and is also backed by Oprah Winfrey and Sony. If the company goes for an IPO, Remark's holding in the small firm could further boost its worth.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD clings to recovery gains near 1.0950 on US Dollar weakness
EUR/USD is holding onto recovery gains near 1.0850 in European trading on Tuesday amid a broadly weaker US Dollar. The recovery in risk sentiment undermines the havem demand for the US Dollar, lifting the pair. Dovish Fed expectations also weigh negatively on the Greenback. Tariff updates eyed.
GBP/USD pares back gains toward 1.2750
GBP/USD is paring back gains to revisit 1.2750 in Tuesday's European session. The pair draws support from renewed US Dollar weakness and a positive shift in risk sentiment but US President Trump's tariff war and global growth concerns limit its upside.
Gold bounces back above $3,000 as trade war tensions flair up
Gold price is bouncing higher in tandem with Equities after another stellar nosedive move on Monday. The precious metal trades just above the $3,000 mark at the time of writing on Tuesday. The bounce is supported by a technical element on the one hand and a geopolitical driver on the other.
XRP battles tariff turbulence amid MVRV buy signal
Ripple seeks stability in a volatile crypto landscape influenced by macroeconomic factors, including reciprocal tariffs. The international money transfer token hit a low of $1.64 on Monday after opening the week at $1.92, representing a 14.5% daily drop.
Strategic implications of “Liberation Day”
Liberation Day in the United States came with extremely protectionist and inward-looking tariff policy aimed at just about all U.S. trading partners. In this report, we outline some of the more strategic implications of Liberation Day and developments we will be paying close attention to going forward.
The Best brokers to trade EUR/USD
SPONSORED Discover the top brokers for trading EUR/USD in 2025. Our list features brokers with competitive spreads, fast execution, and powerful platforms. Whether you're a beginner or an expert, find the right partner to navigate the dynamic Forex market.